Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Susan Shortreed and Sascha Dublin.
Susan Shortreed
Connection Strength
3.788
Sascha Dublin
  1. Maternal and neonatal outcomes of antihypertensive treatment in pregnancy: A retrospective cohort study. PLoS One. 2022; 17(5):e0268284.
    View in: PubMed
    Score: 0.856
  2. Increased COVID-19 Infection Risk Drives Racial and Ethnic Disparities in Severe COVID-19 Outcomes. J Racial Ethn Health Disparities. 2022 Jan 24.
    View in: PubMed
    Score: 0.838
  3. Association Between Diabetes Severity and Risks of COVID-19 Infection and Outcomes. J Gen Intern Med. 2023 Feb 16.
    View in: PubMed
    Score: 0.225
  4. Identifying hypertensive disorders of pregnancy, a comparison of two epidemiologic definitions. Front Cardiovasc Med. 2022; 9:1006104.
    View in: PubMed
    Score: 0.222
  5. Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection or Hospitalization: A Cohort Study. Am J Hypertens. 2021 04 20; 34(4):339-347.
    View in: PubMed
    Score: 0.199
  6. Response to "ACE-2 Downregulation and Incidence of Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Infection". Am J Hypertens. 2021 04 20; 34(4):427.
    View in: PubMed
    Score: 0.199
  7. Renin-angiotensin-aldosterone system inhibitors and COVID-19 infection or hospitalization: a cohort study. medRxiv. 2020 Jul 07.
    View in: PubMed
    Score: 0.188
  8. Identifying hypertension in pregnancy using electronic medical records: The importance of blood pressure values. Pregnancy Hypertens. 2020 Jan; 19:112-118.
    View in: PubMed
    Score: 0.182
  9. Early Pregnancy Hemoglobin A1C and Pregnancy Outcomes: A Population-Based Study. Am J Perinatol. 2018 Nov 30.
    View in: PubMed
    Score: 0.168
  10. Impact of initiatives to reduce prescription opioid risks on medically attended injuries in people using chronic opioid therapy. Pharmacoepidemiol Drug Saf. 2019 Jan; 28(1):90-96.
    View in: PubMed
    Score: 0.167
  11. Impact of Chronic Opioid Therapy Risk Reduction Initiatives on Opioid Overdose. J Pain. 2019 Jan; 20(1):108-117.
    View in: PubMed
    Score: 0.166
  12. Prevalence of prescription opioid use disorder among chronic opioid therapy patients after health plan opioid dose and risk reduction initiatives. Int J Drug Policy. 2017 08; 46:90-98.
    View in: PubMed
    Score: 0.153
  13. Impact of Opioid Dose Reduction and Risk Mitigation Initiatives on Chronic Opioid Therapy Patients at Higher Risk for Opioid-Related Adverse Outcomes. Pain Med. 2018 12 01; 19(12):2450-2458.
    View in: PubMed
    Score: 0.042
  14. Doctor-Patient Trust Among Chronic Pain Patients on Chronic Opioid Therapy after Opioid Risk Reduction Initiatives: A Survey. J Am Board Fam Med. 2018 Jul-Aug; 31(4):578-587.
    View in: PubMed
    Score: 0.041
  15. Comparing Pain and Depressive Symptoms of Chronic Opioid Therapy Patients Receiving Dose Reduction and Risk Mitigation Initiatives With Usual Care. J Pain. 2018 Jan; 19(1):111-120.
    View in: PubMed
    Score: 0.039
  16. Impact of an opioid risk reduction initiative on motor vehicle crash risk among chronic opioid therapy patients. Pharmacoepidemiol Drug Saf. 2017 01; 26(1):47-55.
    View in: PubMed
    Score: 0.037
  17. The Impact of Opioid Risk Reduction Initiatives on High-Dose Opioid Prescribing for Patients on Chronic Opioid Therapy. J Pain. 2016 Jan; 17(1):101-10.
    View in: PubMed
    Score: 0.034
  18. Sex and Age Differences in Global Pain Status Among Patients Using Opioids Long Term for Chronic Noncancer Pain. J Womens Health (Larchmt). 2015 Aug; 24(8):629-35.
    View in: PubMed
    Score: 0.033

© 2024 Kaiser Permanente